These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19846841)

  • 1. Lost in transmission--FDA drug information that never reaches clinicians.
    Schwartz LM; Woloshin S
    N Engl J Med; 2009 Oct; 361(18):1717-20. PubMed ID: 19846841
    [No Abstract]   [Full Text] [Related]  

  • 2. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806
    [No Abstract]   [Full Text] [Related]  

  • 3. Sleeping pills, insomnia and medical practice.
    Solomon F; White CC; Parron DL; Mendelson WB
    N Engl J Med; 1979 Apr; 300(14):803-8. PubMed ID: 34097
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA drug information that never reaches clinicians.
    Messerli FH; Bangalore S
    N Engl J Med; 2010 Feb; 362(6):562; author reply 563. PubMed ID: 20175300
    [No Abstract]   [Full Text] [Related]  

  • 5. The pit (of sleeplessness) and the pendulum (of regulation).
    Bliwise DL
    Sleep Med; 2010 Jan; 11(1):7-8. PubMed ID: 19945339
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on sedative hypnotics.
    FDA Drug Bull; 1979 Aug; 9(3):16-8. PubMed ID: 38166
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA drug information that never reaches clinicians.
    Casoy J
    N Engl J Med; 2010 Feb; 362(6):561; author reply 563. PubMed ID: 20175299
    [No Abstract]   [Full Text] [Related]  

  • 8. Sleeping pills: are they worth the risk?
    Consum Rep; 2006 Sep; 71(9):48-9. PubMed ID: 16929577
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it worth the trouble? The new policy on dissemination of information on off-label drug use under the Food and Drug Administration Modernization Act of 1997.
    Weeks EA
    Food Drug Law J; 1999; 54(4):645-65. PubMed ID: 11824459
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA-Approved Drugs to Treat Sleep Disorders.
    J Psychosoc Nurs Ment Health Serv; 2019 Oct; 57(10):5-6. PubMed ID: 31573658
    [No Abstract]   [Full Text] [Related]  

  • 11. Clip & Save Drug Chart: FDA-approved drugs to treat sleep disorders.
    J Psychosoc Nurs Ment Health Serv; 2010 Oct; 48(10):7-8. PubMed ID: 20954585
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA-Approved Drugs to Treat Sleep Disorders.
    J Psychosoc Nurs Ment Health Serv; 2017 Oct; 55(10):17-18. PubMed ID: 28967971
    [No Abstract]   [Full Text] [Related]  

  • 13. The risks of pharmacological therapy for insomnia (part 2): update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2007; 21(5):231-3. PubMed ID: 17978622
    [No Abstract]   [Full Text] [Related]  

  • 14. Zolpidem and driving impairment--identifying persons at risk.
    Farkas RH; Unger EF; Temple R
    N Engl J Med; 2013 Aug; 369(8):689-91. PubMed ID: 23923991
    [No Abstract]   [Full Text] [Related]  

  • 15. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 16. Inappropriate advertising of dietary supplements.
    Taylor H
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12773657
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA-approved drugs to treat sleep disorders.
    J Psychosoc Nurs Ment Health Serv; 2011 Oct; 49(10):11-2. PubMed ID: 21985567
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concepts in pharmacotherapy of insomnia].
    Jordan W; Hajak G
    Internist (Berl); 1996 May; 37(5):490-9. PubMed ID: 9011548
    [No Abstract]   [Full Text] [Related]  

  • 19. Insomnia medication: do published studies reflect the complete picture of efficacy and safety?
    Mattila T; Stoyanova V; Elferink A; Gispen-de Wied C; de Boer A; Wohlfarth T
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):500-7. PubMed ID: 21084176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans.
    Hall RF; Sobotka E
    Food Drug Law J; 2007; 62(1):1-48. PubMed ID: 17444025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.